COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

CARDIOVASCULAR & IMAGING RESEARCH FOUNDATION OF NY

Lloyd Harbor, NY · EIN 202597925 · Form 990 · FY2024 · NTEE H43 · Medical Research · Micro (<$100K)
revenue
$87K
expenses
$667K
net assets
$421K
employees
4
volunteers
5
program ratio
95%
mission · from form 990

Cardiovascular & Imaging Research Foundation of New York's mission statement is to support medical research and education and other projects aimed at treating and preventing cardiovascular diseases.

profile · synthesized from sources

Cardiovascular & Imaging Research Foundation of New York supports medical research and education focused on the treatment and prevention of cardiovascular diseases. The organization conducts clinical trials and diagnostic evaluations, including studies on stress testing, coronary CT angiography, and advanced imaging technologies. It also supports training programs for cardiologists and cardiovascular technologists.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $253K
    Retrospective clinical trial to assess diagnostic accuracy of stress testing vs Coronary CT Angiography in an outpatient physician office setting
  2. #2 $63K
    Evaluate a new design for the treatment of various coronary disease with enhanced external counter pulsation therapy
named programs · 6 · from sources

What they call their work

4D MRI Accuracy Study
Study evaluating 4D Magnetic Resonance Imaging versus traditional 2D MRI for cardiac conditions
COVID-19 Impact Study
Study evaluating the effects of COVID-19 on patients with non-obstructive heart disease
Cardiology Education Program
Training and certification programs for cardiologists, cardiovascular technologists, and staff
Diagnostic Accuracy Study
Retrospective clinical trial comparing stress testing and Coronary CT Angiography for outpatient diagnosis
Enhanced External Counterpulsation Research
Research on new designs and technology implementations for treating coronary disease
Pharmaceutical Evaluation Trial
Clinical trial assessing a new pharmaceutical for patients with multiple cardiovascular diseases
activities · 3 groups

What they do

  • Biomedical Research and Innovation 2 activities
    • Advancing cardiac imaging techniques through comparative technology assessment
      Assessed the diagnostic accuracy of 4D Magnetic Resonance Imaging compared to traditional 2D cardiac MRI in evaluating cardiac conditions, contributing to the development of more precise imaging protocols.
    • Conducting clinical trials on cardiovascular diagnostics and treatments
      Conducted multiple clinical trials evaluating diagnostic methods such as stress testing versus Coronary CT Angiography, and assessing new pharmaceutical treatments for patients with multiple cardiovascular diseases. Also studied the impact of COVID-19 on patients with non-obstructive heart disease.
  • Medical Professional Education & Training 1 activity
    • Supporting education and training in cardiovascular technology
      Provided support for educational programs, including staff training and certification in cardiology and cardiovascular technology, to enhance professional capacity in the field.
  • Uncategorized 1 activity
    • Developing and evaluating enhanced external counterpulsation (EECP) technologies and therapies
      Designed and implemented advanced enhanced external counterpulsation equipment for cardiovascular diseases, and evaluated a new therapeutic design using EECP for treating various coronary conditions.
financials · form 990 · fy2024
revenue
Total revenue$87K
Contributions & grants$86K99%
Program service revenue$00%
Investment income$3900%
Other revenue$816
expenses
Total expenses$667K
Program expenses95%
Admin / overhead5%
Fundraising0%
Salaries & benefits$380K
Grants paid out$236K
Largest expense lineCompensation
balance sheet
Total assets$421K
Cash$421K
Investments$0
Liabilities$0
Net assets$421K
Liquid reserves7.6 mo
5 years on record · 2020–2024 · YoY revenue -4.2%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 3
NameTitleHours/wkCompensation
Michael Poon Principal Investigator 14 $200K
Pamela Noack Research Director and Investigator 10 $100K
Michael J Cortegiano Treasurer 10 $30K
board members · 3
  • Charles Gargano — Drector
  • Gerald Rausnitz — Director
  • Howard Printz — Director
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Research and Education for Cardiovascular Health
    methodology: medical_research_and_education
    By supporting research and education initiatives, we advance cardiovascular health because generating and disseminating clinical knowledge leads to improved prevention and treatment of cardiovascular diseases.